Despite the relatively evident tumor-suppressive roles of TLR1 and TLR3, controversies have been reported, such as the promoted tumor growth and cisplatin resistance observed in head and neck cancer cells as a result of activated TLR3 signaling [61]. This evidence concerns the gene TLR3 and head and neck cancer.